Biotech IPO window is open, but big pharma M&As set the pace: bankers
Public markets are beginning to reopen for biotech companies after several years of subdued activity. But stronger companies are still…
Biotechnology and pharmaceuticals
Lilly, Novo and Pfizer seek new weight loss drugs
Drug makers have only been introducing GLP-1 pills for a few months and are undergoing big changes to the way…
CVS Health Executives on Reducing Healthcare's Biggest Pain Points
Nikolas Kokovlis | Nurfoto | fake images A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing…
Novo Nordisk and Eli Lilly launch anti-obesity pills and prepare for Medicare coverage
Nordisk and Eli Lilly They took their battle against the GLP-1 pill to the biggest meeting on obesity this weekend…
Shares of weight-loss drug makers plunge 25% as safety data spooks investors
Shares in weight-loss drug maker Zealand Pharma plunged as much as 26% on Monday after new data on its experimental…
Abivax Shares Plunge Amid Cancer Cases in Bowel Disease Drug Trial
Actions of Abivax It closed down 43.6% on Tuesday after reporting new data on its top asset, an ulcerative colitis…
Summit Akeso ivonescimab improves survival in Harmoni-6 trial
Piotr Swat | Light rocket | fake images An experimental drug against lung cancer from Akeso and Summit Therapeutics reduced…
Replimune to reintroduce melanoma drug after Makary leaves FDA
Thomas Fuller | Light rocket | fake images Replimune plans to resubmit its melanoma drug to the Food and Drug…
Eli Lilly's weight-loss drug retatrutide passes obesity trial
Eli Lilly on Thursday said its next-generation drug passed a crucial late-stage trial in obese patients, achieving significant weight loss…
White House Adds Generic Drugs to TrumpRx Direct-to-Consumer Site
President Donald Trump speaks to introduce the TrumpRx website in the South Court Auditorium of the White House in Washington,…